Announcements Trials
Browse Landscape

Phase

Phase 1/2 2

Status

Completed 7Terminated 2Withdrawn 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2Lymphoid 1

Conditions

Neoplasms 2Melanoma 2Brain Neoplasms 2Squamous Cell Carcinoma of Head and Neck 1Salivary Gland Neoplasms 1Neoplasm Metastasis 1Lymphoma 1Lymphatic Metastasis 1Lung Neoplasms 1Hypoxia 1Hematologic Neoplasms 1Head and Neck Neoplasms 1Disease 1Central Nervous System Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1

Interventions

Temozolomide 28Radiosurgery 19Radiotherapy 17Bevacizumab 12Magnetic Resonance Spectroscopy 9Radiation 6Erlotinib Hydrochloride 6Carboplatin 6Topotecan 5Nivolumab 5Mental Status and Dementia Tests 5Irinotecan 5Capecitabine 5pembrolizumab 4dabrafenib 4Trastuzumab 4Sunitinib 4Pemetrexed 4Ipilimumab 4Filgrastim 4Cyclophosphamide 4Aminolevulinic Acid 42,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 4cabozantinib 3Vorinostat 3TPI-287 3Specimen Handling 3Radiotherapy, Intensity-Modulated 3Methylphenidate 3Lomustine 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Brain Neoplasms × alovudine × Clear all
NCT03276676 2024-12-27

[18F]Fluciclovine and [18F]FLT PET/CT Assessment of Primary High-Grade Brain Tumors

University of Utah

Phase 1/2 Terminated
10 enrolled 7 charts
CNS

Brain Neoplasms

NCT01065805 2019-08-22

A Study to Demonstrate the Safety and Preliminary Efficacy of 18F-FLT in Patients With Solid Tumours or Lymphoma

AHS Cancer Control Alberta

Phase 1/2 Terminated
94 enrolled
CNSLymphoid

Brain Neoplasms, Lymphoma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡